StockNews.com initiated coverage on shares of Horizon Therapeutics Public (NASDAQ:HZNP – Free Report) in a research report sent to investors on Sunday. The firm issued a buy rating on the biopharmaceutical company’s stock. Separately, TheStreet downgraded shares of Horizon Therapeutics Public from a b- rating to a c+ rating in a research note on Monday, […]
Horizon Therapeutics Public (NASDAQ:HZNP) Earns Buy Rating from Analysts at StockNews com kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
StockNews.com began coverage on shares of Horizon Therapeutics Public (NASDAQ:HZNP – Free Report) in a report issued on Saturday morning. The firm issued a buy rating on the biopharmaceutical company’s stock. Separately, TheStreet downgraded Horizon Therapeutics Public from a b- rating to a c+ rating in a research note on Monday, May 8th. Eight analysts […]
StockNews.com assumed coverage on shares of Horizon Therapeutics Public (NASDAQ:HZNP – Free Report) in a research note issued to investors on Friday morning. The brokerage issued a buy rating on the biopharmaceutical company’s stock. Separately, TheStreet cut Horizon Therapeutics Public from a b- rating to a c+ rating in a report on Monday, May 8th. […]
Commission pauses major biopharma transaction involving drugs priced in the hundreds of thousands of dollars. As part of the Federal Trade Commission s promised campaign to protect competition in the.